Search results
25 lip 2019 · The findings of our systematic review and meta-analysis show beneficial treatment effects of testosterone for postmenopausal women on a comprehensive array of sexual function domains, the frequency of satisfying sexual events, and sexually associated personal distress.
25 mar 2020 · A recent systematic review and meta-analysis of testosterone treatment in women has provided robust support for a trial of testosterone in women when clinically indicated. In postmenopausal women, testosterone supplementation improved several domains of sexual response, including sexual desire, pleasure, arousal, orgasm, and self-image. 4
5 paź 2022 · This article reviews the literature on the relationship of androgen decline and HSDD, describes our methodology for evaluation, diagnosis of HSDD, and the use of TRT in treating postmenopausal...
22 lip 2022 · It is estimated to affect approximately one in ten women. Menopausal status has a significant impact on the prevalence of HSDD, with several studies showing that the prevalence of HSDD is greatest in younger, surgically menopausal women (16–26%) compared with naturally pre-menopausal women (7–14%).
This article reviews the literature on the relationship of androgen decline and HSDD, describes our methodology for evaluation, diagnosis of HSDD, and the use of TRT in treating postmenopausal...
1 gru 2021 · Transdermal testosterone therapy, at physiologic doses, demonstrates a moderate improvement in HSDD in postmenopausal women. • Local testosterone and DHEA therapy are effective to treat GSM caused by vaginal atrophy. • It is important to monitor total testosterone levels during treatment to keep them in the physiologic, premenopausal range. •
4 gru 2019 · The only evidence-based indication for testosterone therapy in women is HSDD, diagnosed in postmenopausal women after biopsychosocial assessment (Level I, Grade A) 2, 6; testosterone...
